Updated:
The Eleven Fund
The Eleven Fund is a multi-strategy growth investor that makes equity investments in early and high growth stages of company development. It invests in public...
The Eleven Fund
The Eleven Fund is a multi-strategy growth investor that makes equity investments in early and high growth stages of company development. It invests in public and private equity markets, focusing on Technology, Life Sciences, and Consumer sectors. The Eleven Fund has invested in two companies: Escient Pharmaceuticals in 2022 and one other undisclosed investment.
General information
Firm type
Private Equity
Year founded
2017
Location
Region
North America
Country
United States
City
Denver
Corporate office
Denver, CO, United States
Frequently asked questions
Who runs investment decisions at The Eleven Fund?
No named principals appear in the firm's own public communications or in third-party reporting. The Eleven Fund's website does not identify a founder, managing partner, or investment committee. For institutional allocators, this represents a threshold due-diligence gap — the identity of the key decision-maker cannot be confirmed without direct outreach to the firm.
Does The Eleven Fund participate in fund commitments or only direct deals?
The Eleven Fund's stated strategy focuses on direct investments across stages — early, expansion, and pre-IPO — without referencing fund-of-funds commitments. No publicly available data confirms whether the firm also acts as a limited partner in other managers' funds.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: